Trichosanthin
Alternative Names: Alpha-Trichosanthin; Compound Q; GLQ 223; PEG-GLQ 223Latest Information Update: 25 Sep 2021
At a glance
- Originator Unknown
- Developer Genelabs Technologies
- Class Antineoplastics; Antivirals
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; HIV infections
Most Recent Events
- 25 Nov 1998 Discontinued-II for HIV infections treatment in USA (IV)
- 25 Nov 1998 Discontinued-Preclinical for Cancer in USA (Unknown route)